Skip to main content

Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million

Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Report for Quarter Ended March 31, 2026 (Appendix 4C) NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the third fiscal quarter ended March 31, 2026. “We’ve had a busy and exciting March quarter marked by a series of major achievements. Ryoncil® revenues are now approaching US$100 million since last year’s launch, we have substantially improved our net operating cash spend, our pivotal trial in inflammatory back pain has successfully achieved its patient recruitment target, and we have bolstered our long-term leadership in the field by acquiring genetically modified technology...

Continue reading

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Fourth quarter 2025 revenue up 75% compared to the fourth quarter 2024 Fourth quarter 2025 gross profit increased 78% compared to the fourth quarter 2025 Fourth quarter same-store sales up 6% and same-store prescription sales up 3.8 %, supplementary financial measures, both compared to fourth quarter 2025SASKATOON, Saskatchewan, April 29, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy acquisition and ownership platform for pharmacist-led community pharmacy ownership, today reported its financial results for fourth quarter and year ended December 31, 2025. “Our financial results reflect our steady progress in scaling the business through disciplined M&A, the successful integration of recently acquired stores, and the operational excellence of our pharmacies,”...

Continue reading

Vaccinex Reports 2025 Annual Financial Results

ROCHESTER, N.Y., April 29, 2026 (GLOBE NEWSWIRE) — Vaccinex, Inc. (OTCMKTS:VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in Alzheimer’s, Huntington’s disease, and cancer today released financial results for the year ended December 31, 2025. The financial statements have been posted on the company website. About Vaccinex, Inc. Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders, and is currently initiating a new Phase 2b study in Alzheimer’s disease. Vaccinex is based in Rochester, New York. Investor ContactElizabeth Evans, PhDChief Operating Officer, Vaccinex, Inc.(585)...

Continue reading

Jura Announces Filing of Year End 2025 Financial Statements, MD&A and Reserves Report

CALGARY, Alberta, April 29, 2026 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company”) today announced the filing on SEDAR+ of its consolidated annual audited financial statements and management’s discussion and analysis for the years ended December 31, 2025 and 2024, as well as National Instrument 51-101 – Standards of Disclosure for Oil and Gas Activities, Form 51-101F1 Statement of Reserves Data and Other Oil and Gas Information as of December 31, 2025 (the “2025 Reserves Report”). As disclosed previously, Jura’s subsidiaries are involved in ongoing arbitrations (the “PEL Arbitrations”) with Petroleum Exploration (Private) Limited (“PEL”), the operator of the Badin IV North and Badin IV South blocks (together the “Badin Blocks”). Despite the arbitral award issued in favour of Jura’s...

Continue reading

Forefront Tech Holdings Acquisition Corp Announces Pricing of $100,000,000 Initial Public Offering

Grand Cayman, Cayman Islands, April 29, 2026 (GLOBE NEWSWIRE) — Forefront Tech Holdings Acquisition Corp (the “Company”) announced today the pricing of its initial public offering of 10,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Global Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading on April 30, 2026, under the ticker symbol “FTHAU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants...

Continue reading

LogicMark, Inc. to Announce First Quarter 2026 Financial Results on May 13, 2026

LOUISVILLE, Ky., April 29, 2026 (GLOBE NEWSWIRE) — LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, will release its financial results for the first quarter ended March 31, 2026, after the market close on Wednesday, May 13, 2026. Ms. Chia-Lin Simmons, CEO, and Mr. Mark Archer, CFO, will also host a live call and webcast the same day at 4:30 PM (EDT) / 1:30 PM (PDT) to review the results. To listen to the live webcast, please visit the LogicMark Investor Relations website or use the link: https://edge.media-server.com/mmc/p/pc9vm77u Analysts wishing to participate in the live call should register here:https://register-conf.media-server.com/register/BIc30647f970864cb5a40fcf4166c9f751 The associated press release, SEC...

Continue reading

Mustang Energy Corp. Announce Results from Drilling Program at Surprise Creek Project, Saskatchewan

VANCOUVER, British Columbia, April 29, 2026 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE: MEC, OTC:MECPF, FRA:92T) (the “Company” or “Mustang”) is pleased to announce it has received assay results from all 11 diamond drill holes on the Surprise Creek Uranium-Copper (“Surprise Creek” or the “Project”), located in a prospective region known for its mineral potential northwest of the Athabasca Basin. The Company entered into an option agreement (the “Option Agreement”) with Thunderbird Resources Ltd. (“Thunderbird”) to acquire an undivided 80% interest in the Project. Please refer to the Company’s news release dated June 4, 2025, and June 16, 2025, as filed under the Company’s SEDAR+ profile, for further details regarding the Option Agreement. Surprise Creek Uranium-Copper Project The Project is located 25 km north-west of the Beaverlodge...

Continue reading

Mountain Crest Acquisition 6 Corp. Announces Pricing of $60 Million Initial Public Offering

NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) — Mountain Crest Acquisition 6 Corp. (the “Company”), a blank check company incorporated as a British Virgin Islands business company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 6,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one ordinary share and one right. Each right entitles the holder to receive one-fourth (1/4) of one ordinary share upon consummation of the Company’s initial business combination. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “MCAHU” beginning on April 30, 2026. Once the securities...

Continue reading

United States Lime & Minerals Reports First Quarter 2026 Results and Declares Regular Quarterly Cash Dividend

DALLAS, April 29, 2026 (GLOBE NEWSWIRE) — United States Lime & Minerals, Inc. (NASDAQ: USLM) today reported first quarter 2026 results: The Company’s revenues in the first quarter 2026 were $87.8 million, compared to $91.3 million in the first quarter 2025, a decrease of $3.4 million, or 3.7%. The decrease in revenues in the first quarter 2026, compared to the first quarter 2025, resulted primarily from decreased sales volumes, principally due to decreased demand from the Company’s construction, oil and gas services, and roof shingle customers, partially offset by increased demand from the Company’s steel customers. During the first quarter 2026, the Company caught up on most of the weather-related shipping interruptions that resulted from the January winter storm. The Company’s gross profit was $41.8 million in the first quarter...

Continue reading

Inno Holdings Inc. Announces 1-for-20 Reverse Stock Split in Ongoing Nasdaq Compliance Efforts

Hong Kong, April 29, 2026 (GLOBE NEWSWIRE) — INNO HOLDINGS INC. (NASDAQ: INHD) (“INNO” or the “Company”), a holding company incorporated in the State of Texas and a trade-focused electronic products trading company with operations primarily in Hong Kong through its Hong Kong subsidiaries, today announced that its Board of Directors has approved an 1-for-20 reverse stock split of all its issued and outstanding common stock pursuant to the authorization grated from the annual meeting of the Company’s stockholders on March 2, 2026. The Company has filed an amendment to its certificate of formation, as amended, with the Secretary of State of the State of Texas to effect the reverse stock split. The reverse stock split will become effective on May 4, 2026 at 09:30 a.m., Eastern Time. The reverse stock split will not affect the par value...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.